Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,273 | -14,648 | -12,518 | -9,445 | -8,636 |
| Depreciation Amortization | 1,400 | 3,888 | 2,530 | 879 | 801 |
| Accounts receivable | 15 | -3 | 9 | -32 | 87 |
| Accounts payable and accrued liabilities | 85 | 97 | -516 | 186 | -113 |
| Other Working Capital | 572 | 540 | -46 | 821 | 181 |
| Other Operating Activity | 7,237 | 3,207 | 5,436 | 3,737 | 2,678 |
| Operating Cash Flow | $-1,964 | $-6,919 | $-5,105 | $-3,854 | $-5,003 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -36 | -13 | -4 | -189 |
| Investing Cash Flow | $N/A | $-36 | $-13 | $-4 | $-189 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,290 | 10,888 | 5,058 | 2,542 | 1,894 |
| Debt Repayment | N/A | -5,708 | -863 | -330 | -477 |
| Common Stock Issued | 10 | 1,659 | 589 | 2,080 | 3,711 |
| Other Financing Activity | 727 | 0 | 0 | -15 | -72 |
| Financing Cash Flow | $5,027 | $6,839 | $4,783 | $4,277 | $5,057 |
| Beginning Cash Position | 2 | 118 | 452 | 32 | 167 |
| End Cash Position | 3,065 | 2 | 118 | 452 | 32 |
| Net Cash Flow | $3,063 | $-116 | $-334 | $420 | $-135 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,964 | -6,919 | -5,105 | -3,854 | -5,003 |
| Capital Expenditure | N/A | -36 | -13 | -4 | -189 |
| Free Cash Flow | -1,964 | -6,954 | -5,118 | -3,857 | -5,192 |